Patient Capital Management’s Rocket Companies RKT Stock Holding History

Patient Capital Management’s Portfolio RKT Stock Details RKT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-142,791	Closed	-$2.08M	–	43
2024 Q1	$2.08M	Sell	142,791 -213,886	-60%	-$2.65M	0.1%	37
2023 Q4	$5.16M	Sell	356,677 -40,000	-10%	-$383K	0.27%	35
2023 Q3	$3.24M	Sell	396,677 -95,923	-19%	-$970K	0.19%	36
2023 Q2	$4.41M	Sell	492,600 -15,100	-3%	-$131K	0.25%	34
2023 Q1	$4.6M	Hold	507,700	–	–	2.05%	28
2022 Q4	$3.55M	Sell	507,700 -30,000	-6%	-$219K	1.73%	27
2022 Q3	$3.4M	Sell	537,700 -95,100	-15%	-$827K	1.7%	29
2022 Q2	$4.66M	Buy	632,800 +424,500	+204%	+$3.67M	2.06%	20
2022 Q1	$2.32M	Sell	208,300 -74,500	-26%	-$922K	0.78%	38
2021 Q4	$3.96M	Buy	+282,800	New	+$4.5M	1.14%	35

Other funds holding RKT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TCMX

Technology Crossover Management X Menlo Park, California $795M AUM 5.23% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Patient Capital Management's RKT Position: Q2 2024 in Review

Patient Capital Management sold out of Rocket Companies (RKT) in Q2 2024, closing a stake of 142,791 shares — an estimated $2.08M sold.

Patient Capital Management first reported a position in RKT in Q4 2021 and held it in 10 quarters. The position peaked at $5.16M in Q4 2023. 254 funds tracked by Wall St. Rank hold RKT as of Q2 2024.

Patient Capital Management reported no remaining Rocket Companies position as of Q2 2024 after selling out during the quarter.
Patient Capital Management sold 142,791 Rocket Companies shares in Q2 2024, an estimated $2.08M.
Patient Capital Management first reported a position in Rocket Companies in Q4 2021 and held it in 10 quarters.
Patient Capital Management's Rocket Companies position peaked at $5.16M in Q4 2023.
254 funds tracked by Wall St. Rank held Rocket Companies as of Q2 2024.

Based on Patient Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.